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Abstract Background and aim: A large number of mitochondrial DNA (mtDNA)
mutations have been implicated in degenerative diseases and aging. The aim of this
study was to evaluate whether the 15497 G/A mtDNA polymorphism (G251S) in the
cytochrome b subunit of respiratory complex III, which has been associated with
obesity-related variables and lipid metabolism in a Japanese population, is
associated with severe obesity also in adult Caucasians from southern Italy.
Methods and results: Unrelated severely obese patients (nZ 317; BMIO 40 kg/m2)
and controls (n Z 217; BMI ! 25 kg/m2) from Southern Italy were genotyped by
allelic discrimination TaqMan assay for the 15497 G/A mtDNA polymorphism. In
obese patients fasting serum total cholesterol, triglycerides, HDL-cholesterol and
glucose were measured enzymatically and sitting blood pressure and heart rate
were also collected. Mean levels of total cholesterol, triglycerides and glucose were
below the upper reference limit for healthy subjects. Female obese subjects
showed lower levels of blood pressure and heart rate and higher levels of
HDL cholesterol than male obese patients (P! 0.001). All the control subjects and
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MTCYB polymorphism in Caucasian obesity 467315/317 severely obese patients were homozygous for the G allele (wild type),
whereas only 2/317, were females homozygous for the A allele.
Conclusions: The mtDNA 15497 G/A polymorphism in cytochrome b was present in
0.6% obese subjects, two females whose lipid parameters and BMI were similar to
those of the overall group. Therefore, this mutation may appear to contribute in
rare instances to severe obesity but does not explain the majority of cases in our
population. A more extensive genetic haplogroup characterization is required to
identify associations to obesity in Caucasians.
ª 2005 Elsevier B.V. All rights reserved.Introduction
Changes in mitochondrial DNA (mtDNA) influence
human health. They may contribute to select
individuals with advantageous metabolic pheno-
types for longevity or individuals with enhanced
susceptibility to degenerative diseases [1,2]. Mito-
chondrial DNA is maternally inherited; it has a very
highmutation rate (10 fold that of nuclear DNA) and
consists of a non-coding region (D-loop or control
region) and a functional region that encodes two
rRNAs (12S and 16S), 22 tRNAs and 13 polypeptides
[3,4]. The latter are subunits of the 5-enzyme
complexes (IeV) that are involved in the mitochon-
drial electron-transfer chain [4]. Cytochrome b is
the only mtDNA-encoded subunit of respiratory
complex III. The cytochrome b single nucleotide
polymorphism (SNP) 15497 G/A, which leads to
a glycine 251 serine (Gly251Ser) amino acid re-
placement, has been associated with obesity in
a Japanese population. In fact, individuals bearing
the A allele presented awaist-to-hip ratio and other
obesity-related variables including triglycerides
levels, greater than individuals bearing the G allele
[5]. Because human mtDNA undergoes geographical
variations, and because mtDNA variants are often
functionally different [6], we determined whether
the mtDNA 15497 G/A polymorphism is involved in
obesity also in a Caucasian population. Thus, we
studied this polymorphism in 317 severely obese and
in 217 controls unrelated adult Italians from the
same geographical area of Southern Italy.
Methods
Subjects were recruited from the Out-Patients
Laboratory Service (217 control subjects: 98 males
and 119 females, BMI! 25 kg/m2) and from the
Out-Patients Obesity Clinic (317 patients with
severe obesity: 126 males and 191 females with
BMIO 40 kg/m2; no diabetes and no coronary
heart disease) of the School of Medicine, Univer-
sity of Naples Federico II. The families of all
subjects had lived in the same region of SouthernItaly for at least two generations. Informed con-
sent to participate in the study was obtained from
each subject, and the study was approved by the
Ethics Committee of our Medical School.
Serum total cholesterol (T Chol), triglycerides
(Tg) and glucose (Glu) were measured enzymati-
cally with standard techniques on an automated
analyzer (Hitachi 747; Boehringer Mannheim). The
HDL-cholesterol (HDL-Chol) concentration was de-
termined enzymatically by measuring cholesterol in
the supernatant after precipitation with phospho-
tungstate. The body mass index (BMI) was calculated
as ratio weight (kg)/height (m2). Systolic (SBP) and
diastolic (DBP) blood pressure and heart rate (HR)
were also collected by standard procedures.
Genomic DNA was extracted from peripheral
blood samples with the Nucleon BACC2 kit (Amer-
sham Life Science, England) and the mtDNA 15497
G/A SNPwas assayed, in duplicate, by the Real Time
Taqman method [7]. Briefly, two probes are used in
a biallelic system; one probe is specific for the wild-
type allele and the other is complementary to the
mutant allele. The alleles are distinguished with
fluorogenic probes, which consist of an oligonucle-
otide with a fluorescent reporter dye (VIC or FAM),
a non-fluorescent quencher and a minor groove
binder (MGB) [8]. The lattermolecule formsahyper-
stabilized duplex with complementary DNA thereby
increasing the capacity of the hybridization probe
to discriminate the SNP [9]. The Primer Express
program (Applied Biosystems, Foster City, CA) was
used to design the PCRprimers (forward: 5#ACTTCT
CTT CCT TCT CTC CTT AAT GAC A 3#, and reverse:
5#GGG TTG GCT AGG GTA TAA TTG TCT3#) and the
MGB TaqMan probes (FAM-CCT CCTAAGCGA CCC-Q-
MGB and VIC-CCT CCT AGG CGA CCC-Q-MGB).
Reaction mixtures were assembled in a 384-well
plate using a Biomek 2000 Workstation (Beckman
Instruments, Inc. Fullerton, CA). Each mixture
consisted of: 2 mL (40 ng) of genomic DNA, 36 nM
of primer, 8 nM of probe and 2.5 mL TaqMan Univer-
sal Master mix (Applied Biosystems Foster City, CA)
in a total reaction volume of 5 mL. Together with
samples from patients, we tested negative (i.e., no
DNA sample) and positive controls (i.e., G/G and
468 R. Liguori et al.A/A homozygotes and a G/A heterozygote, ob-
tained by mixing G/G and A/A DNA samples, for
the 15497 G/A SNP). The positive controls had been
previously typed by sequence analysis on an ABI
3100 Genetic Analyzer (Applied Biosystems Foster
City, CA). Real time PCR was performed on an ABI
Prism 7900-HT instrument with the Sequence De-
tection System (SDS 2.1) and the SDS Enterprise
Database (Applied Biosystems Foster City, CA). The
amplification protocol consisted of 95 C for 10 min;
95 C for 15 s and 60 C for 1 min for 40 cycles with
a final soak at 25 C. During PCR, each TaqMan MGB
probe anneals specifically to the complementary
sequence. When the probe is intact, the proximity of
the quencher to the reporter dye reduces the
fluorescence signal, whereas when the fluorogenic
probe is hybridized to the target sequence, it is
cleaved by AmpliTaq Gold DNA polymerase. The
cleavage results in the release of the reporter dye
and the consequent increased fluorescence indicates
that the specific probe target has been amplified. In
each amplification step, the intensity of fluorescence
increases in relation to the accumulation of the PCR
product, which is automatically measured directly in
the reaction well. At the end of the PCR, a laser
collects the fluorescence spectrum of each dye and
the SDS software elaborates the data to produce
a scatter diagram of the mtDNA 15497 G/A poly-
morphism. Statistical analysis, Student’s t test, was
performed with SPSS for Windows software (Ver.
11.5). The distribution of genotypes in the severe
obese population was tested (HardyeWeinberg
equilibrium) using Pearson’s chi square test.
Results
Table 1 shows the general and biochemical charac-
teristics of our severely obese Caucasian patients.
Mean levels of total cholesterol, triglycerides and
glucose were below the upper reference limit for
healthy subjects. No statistically significant differ-
ence, evaluated by Student’s t test, was observed
among females and males obese patients except for
mean levels of total cholesterol (P! 0.02) and HDL
cholesterol, SBP, DBP (P! 0.001). MtDNA 15497 G/A
genotypes in obese subjects were not in Hardye
Weinberg equilibrium (PZ 0.001). Fig. 1 shows the
TaqMan allelic discrimination plot of the cytochrome
b 15497 G/A mtDNA polymorphism in both severely
obese patients and control subjects of Southern
Italy. Samples are grouped in distinct clusters. An
increase in the fluorescent signal of VIC or FAM
indicates homozygous genotypes for the G and A
allele, respectively, whereas an increase in both
signals indicates heterozygous genotypes.The screening of the mtDNA 15497 G/A poly-
morphism revealed that all the control subjects
and 315/317 severely obese patients were homo-
zygous for the G allele (wild type), whereas only 2/
317 (0.6%) were homozygous for the A allele. The
general characteristics of these subjects (case1:
a female with BMI 54.5 kg/m2, Glu 6.16 mmol/L, T
Chol 5.12 mmol/L, HDL-Chol 1.29 mmol/L, Tg
1.98 mmol/L; case 2: a female with BMI 56.2 kg/
m2, Glu 5.38 mmol/L, T Chol 5.74 mmol/L, HDL-
Chol 1.65 mmol/L, Tg 0.97 mmol/L) were similar
to those of the overall group.
Discussion
Although many of the mtDNA sequence variants
found in geographically separated populations are
evolutionarily interesting, caution must be exer-
cised in attributing a pathological role to ethnic-
specific variants [10]. In fact, many mtDNA base
substitutions do not affect known genetic func-
tions, whereas others alter conserved amino acids
and can thus lead to mild or severe organ failure or
disease [10]. In particular, the mtDNA 15497 G/A
polymorphism produces a Gly251Ser amino acid
replacement in the cytochrome b protein [1].
Glycine 251 is a relatively well conserved residue
in the ubiquinone binding site of the cytochrome
b protein. Therefore, the replacement of Gly251
by other amino acids could alter ubiquinone-
binding and cause dysfunction of cytochrome b as
occurs for the Gly251Asp substitution associated
with heart failure [1].
Table 1 General and biochemical characteristics
(mean G S.D.) of severely obese Caucasian subjects
of Southern Italy (n Z 317)
Variables Female
(n Z 191)
Male
(n Z 126)
Age (years) 34.1 G 12.7 32.7 G 10.5
BMI (kg/m2) 48.5 G 7.2 48.9 G 8.5
Glucose (mmol/L) 5.20 G 1.2 5.52 G 1.7
Total cholesterol
(mmol/L)a
4.93 G 1.0 4.66 G 0.9
HDL cholesterol
(mmol/L)b
1.24 G 0.2 1.02 G 0.2
Triglycerides
(mmol/L)
1.42 G 0.6 1.59 G 0.9
SBP (mmHg)b 124.5 G 15.9 132.3 G 15.4
DBP (mmHg)b 79.6 G 10.1 84.2 G 10.3
HR (bpm) 79.1 G 10.6 80.4 G 11.3
a P!0.02.
b P!0.001 indicate statistically significant difference
(evaluated by the Student’s t-test) among males and
females.
MTCYB polymorphism in Caucasian obesity 469In this study,which is the first investigation of the
mtDNA 15497 G/A polymorphism in severely obese
Caucasian subjects, we found the Gly251Ser re-
placement in 0.6% of cases. The two patients
homozygous for the A allele, were females aged
respectively 31 and 50 years, with obesity variables
similar to those of the overall group of patients and
triglyceride levels below the upper reference limit
for healthy controls. This finding contrastswith data
obtained in a Japanese population, where the A
allele was detected in 3.5% of 1731 subjects (about
6 fold more than in our Italian Caucasian popula-
tion) in association with obesity-related variables
and increased triglyceride levels [5].
An explanation for this discrepancy could be that
this polymorphism is associated with increased
lipid levels rather than to obesity. In fact, in the
Japanese population both cholesterol and triglyc-
eride levels were higher than in our Caucasian
Figure 1 Allelic discrimination assay of mtDNA 15497
G/A polymorphism. Increases in the fluorescent signal
VIC and/or FAM indicate the homozygous genotype for
the G or A alleles, respectively, whereas an increase in
both signals indicates heterozygous genotypes (A/G).
Very low fluorescent signals (lower part of the figure)
indicate negative controls (-) or unamplified samples
(!), positive controls: G/G, A/G and A/A are circled.obese subjects, whereas the mean BMI (!25 kg/m2)
was lower in the Japanese subjects than in our
severely obese subjects (mean BMIO 48 kg/m2)
withmean triglyceride levels in the reference range
(!2.03 mmol/L).
Mitochondrial DNA genes are involved in energy
production, through ATP synthesized via the oxi-
dative phosphorylation system, both for work
performance and to maintain body temperature,
and differences in nucleotides may reflect adap-
tation to different climates [6]. Thus, the 15497 G/
A SNP, representative of haplogroup G3, is present
in people from central Asia and the Arctic as an
advantageous adaptation to the cold climate,
whereas the same SNP in westernized Japan could
predispose to more fat accumulation and obesity
[11]. Other haplogroups are present in European
Caucasians, such as our Mediterranean population
[12], where natural ancestral selection of different
mtDNA variations probably occurred in relation to
the temperate climate. We plan to investigate
such haplogroups to look for specific associations
with severe obesity. In conclusion, the 15497 G/A
mutation appear to contribute only in rare cases to
severe obesity but does not explain the majority of
cases in our population.
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